Form 4 for UTHR UNITED THERAPEUTICS Corp
Accepted 2021-11-05 00:00:00 ET · period of report 2021-11-04 · accession 0001127602-21-028477 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-05 | 2021-11-04 | UTHR | BENKOWITZ MICHAEL | Pres, COO | M - OptEx | $53.83 | +4,000 | 6,235 | +179% | +$215.3K |
| D | 2021-11-05 | 2021-11-04 | UTHR | BENKOWITZ MICHAEL | Pres, COO | D - Sale to Iss | $201.44 | -4,000 | 2,235 | -64% | -$805.8K |
| D | 2021-11-05 | 2021-11-04 | UTHR | BENKOWITZ MICHAEL | Pres, COO | M - OptEx | $0.00 | -4,000 | 16.0K | -20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-04 | M | A | 4,000 | $53.83 | 6,235 | D | — | — | |
| 2 | Common | Common Stock | 2021-11-04 | D | D | 4,000 | $201.44 | 2,235 | D | — | — | |
| 3 | Derivative | Share Tracking Award | 2021-11-04 | M | D | 4,000 | $0.00 | 16,000 | D | $53.83 · 2018-01-02 to 2023-01-02 | 4,000 Common Stock |